https://www.bristol.ac.uk/news/2022/november/labblood-study....
> "The lab-grown blood cells are all fresh, so the trial team expect them to perform better than a similar transfusion of standard donated red cells, which contains cells of varying ages. Additionally, if manufactured cells last longer in the body, patients who regularly need blood may not need transfusions as often. That would reduce iron overload from frequent blood transfusions, which can lead to serious complications."
They discuss automating the process, but the costs are still likely to be high as you'd need near-clean-room standards of sterility to avoid contamination problems - although that's also a problem with blood donation. Notably, some countries (incl USA, China) allow people to sell their blood, which tends to draw in poor and desperate people who may be more at risk of having transmissible diseases:
https://www.theatlantic.com/business/archive/2018/03/plasma-...
In the long run however, this might become the normal process. Bio-synthetic blood cell production has been talked about for over 20 years, it's cool to see it actually happening. (Synthetic immune system cells are also an interesting possibility, i.e. white blood cells).